Jump to Content Jump to Navigation
VRI Multiplex Test

VRI Mutiplex Test: Syndromic testing in less than 2.5 hours

Kartusche VRI lightblue

Vivalytic VRI Multiplex Test

Viral respiratory infections (VRI) can cause serious respiratory diseases and even spread unnoticed under certain circumstances. Many of them lead to similar symptoms, which often hinders a quick diagnosis. This is exactly where the Vivalytic VRI test comes in.

This multiplex assay tests the patient sample for the SARS-CoV‑2 virus as well as for other relevant viral respiratory tract infections with similar symptoms. With the Vivalytic VRI test, doctors can quickly and efficiently differentiate between the various infections, such as the different types of influenza, and immediately initiate the right treatment. 

The test delivers a reliable result in less than 2.5 hours according to WHO guidelines at the point-of-care, i.e. in the immediate vicinity of the patient’s sample collection. A time-consuming logistics chain, where the samples have to be transported, is therefore not necessary.

Respiratory infections

  • Human adenovirus A/B/C/D/E
  • Human coronavirus 229E/NL63
  • Human coronavirus OC43/HKU1
  • Human enterovirus A/B/C/D
  • Human rhinovirus A/B/C
  • Influenza A virus
  • Influenza B virus
  • MERS coronavirus (MERS-CoV)
  • Sarbecovirus (SARS-CoV, SARS-like CoV, SARS-CoV‑2
  • SARS coronavirus 2 (SARS-CoV‑2)

Product Specifications

Sample Type

Nasopharyngeal and/​or oropharyngeal swab

Sample Input Volume


Reagent Storage Conditions

15 – 25 °C

Ordering Information


Pack size

Order number

Vivalytic VRI

15 cartridges


Loading …